Foundation Medicine awarded a grant to My Style Matters and HYPE to support the Community Outreach for Detection and Education (CODE) initiative, aiming to increase biomarker testing access in Black, Latino, and LGBTQ populations. Additionally, French startup MSInsight participates in the EU-funded PREDI-LYNCH project to develop liquid biopsy tests for Lynch syndrome cancer risk using next-generation sequencing and AI-enhanced microsatellite instability detection. These efforts underscore commitment to precision oncology equity and diagnostic innovation.